期刊文献+

腔隙性脑梗死患者血液流变学变化及前列地尔对其的影响 被引量:5

下载PDF
导出
摘要 目的了解腔隙性脑梗死患者血液流变学变化及前列地尔对其的影响。方法腔隙性脑梗死患者50例分为常规治疗组(n=25)和前列地尔治疗组(n=25);测定脑梗死各组治疗前、后和正常对照组(n=25)的血糖、血脂及血液流变学指标。结果脑梗死各组低切及高切全血粘度、血浆粘度、血沉(ESR)、血沉方程K值、红细胞聚集指数、红细胞刚性指数、纤维蛋白原及血小板聚集率均显著高于正常对照组(P<0.01);红细胞变形指数显著低于对照组(P<0.01)。治疗开始时上述指标在脑梗死各组之间无显著差异(P>0.05);治疗2周后脑梗死各组上述除红细胞变形指数外各项指标均显著低于治疗开始时(P<0.01);红细胞变形指数显著高于治疗开始时(P<0.01),前列地尔治疗组低切全血粘度、血沉、血沉方程K值、红细胞聚集指数、纤维蛋白原及血小板聚集率均显著低于常规治疗组(P<0.01)。结论腔隙性脑梗死患者存在血液流变学异常,即血液粘度、红细胞和血小板聚集性增高,红细胞变形性下降。脑梗死患者常规治疗和加用前列地尔治疗后上述血液流变学异常明显改善,加用前列地尔治疗对腔隙性脑梗死患者红细胞和血小板聚集性的改善更为显著。
出处 《中国血液流变学杂志》 CAS 2007年第1期68-70,共3页 Chinese Journal of Hemorheology
  • 相关文献

参考文献11

  • 1张学亮,何作云,丁秋华,王心明,安世铭,李小鹰,陈卫,袁林贵.NIDDM合并高血压的血液流变学变化及其意义[J].中国血液流变学杂志,1994,4(4):5-7. 被引量:1
  • 2Ciuffetti G,Pasqualini L,Pirro M,et al.Blood rheology in men with essential hypertension and capillary rarefaction[J].J Hum Hypertens,2002,16(8):533~537
  • 3Lee AJ.Haemorheological,platelet and endothelial factors in essential hypertension[J].J Hum Hypertens,2002,16(8):529~531.
  • 4Weinberger J.Diagnosis and prevention of atherosclerotic cerebral infarction[J].CNS Spectr,2005,10(7):553~564.
  • 5Dogne JM,Hanson J,Pratico D.Thromboxane,prostacyclin and isoprostanes:therapeutic targets in atherogenesis[J].Trends Pharmacol Sci,2005,26(12):639~644.
  • 6Hishinuma T,Tsukamoto H,Suzuki K,et al.Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications[J].Prostaglandins Leukot Essent Fatty Acids,2001,65(4):191~196.
  • 7Konieczkowski M,Skrinska VA.Increased synthesis of thromboxane A(2)and expression of procoagulant activity by monocytes in response to arachidonic acid in diabetes mellitus[J].Prostaglandins Leukot Essent Fatty Acids,2001,65(3):133~138.
  • 8Sainani GS,Maru VG.Role of endothelial cell dysfunction in essential hypertension[J].J Assoc Physicians India,2004,52:966~969.
  • 9Satoh K,Imaizumi T,Yoshida H,et al.Plasma 11-dehydrothromboxane B2:a reliable indicator of platelet hyperfunction in patients with ischemic stroke[J].Acta Neurol Scand,1991,83(2):99~102.
  • 10张学亮,廖立生,王心明.糖尿病微血管病变发病机制研究进展[A].孙秉庸;赵修竹;李楚杰主编.病理生理学进展·第五分册[M].北京:科学技术文献出版社,1993.364~373.

共引文献3

同被引文献33

  • 1徐艳丽.78例复发性脑梗死患者血流变学改变的临床分析[J].陕西医学杂志,2008,37(8):1082-1083. 被引量:6
  • 2余慧青,刘建波.前列地尔注射液治疗急性脑梗死的临床研究[J].医学临床研究,2005,22(1):82-83. 被引量:5
  • 3屈宝泽,王化洲.前列地尔对血管内皮保护作用的实验研究[J].中国误诊学杂志,2005,5(13):2401-2402. 被引量:8
  • 4各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33020
  • 5UYUKLU M,MEISELMAN H J,BASKURT O K.Effect of hemoglobin oxygenation level on red blood cell deformability and aggregation[J].Clin Hemorheol Microcirc,2009,41(3):179-188.
  • 6EREMINA V,JEFFERSON J A,KOWALEWSKA J,et al.VEGF inhibition and renal thrombotic microangiopathy[J].N Engl J Med,2008,358(11):1129-1136.
  • 7MUSIELAK M.Red blood cell-deformability measurement:review of techniques[J].Clin Hemorheol Microcirc,2009,42(1):47-64.
  • 8FORNAL M,KORBUT R A,KROLCZYK J,et al.Left ventricular geometry and rheological properties of erythrocytes in patients at cardiovascular disease risk[J].Clin Hemorheol Microcirc,2009,43(3):203-208.
  • 9SAWTELL N M,WEISS M A,PESCE A J,et al.An immune complex glomerulopathy associated with glomerular capillary thrombosis in the laboratory mouse.A highly reproducible accelerated model utilizing cationized antigen[J].Lab Invest,1987,56(3):256-263.
  • 10Dogne JM, Hanson J, Prmico D. Thromhoxane, prostacyclm and isoprostanes: therapeutic targets in atherogenesis[J].Trends Pharmacol Sci, 2005,26 (12) : 639-644.

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部